6MWD |
6 min walk test distance |
6MWT |
6 min walk test |
AA |
ascending aorta |
CMR |
cardiac MRI |
CT |
computed tomography |
CTEPH |
chronic thromboembolic pulmonary hypertension |
DECT |
dual-energy CT |
DLCO |
lung diffusing capacity for carbon monoxide |
ERA |
endothelin receptor antagonist |
ESC/ERS |
European Society of Cardiology/European Respiratory Society |
FEV1 |
forced expiratory volume in 1 s |
FVC |
forced vital capacity |
ILD |
interstitial lung disease |
LTx |
lung transplantation |
LV |
left ventricle |
MRI |
magnetic resonance imaging |
NYHA |
New York Health Organization |
OSAS |
obstructive sleep apnea syndrome |
PA |
pulmonary arteries |
PAH |
pulmonary arterial hypertension |
PAWP |
pulmonary artery wedge pressure |
PDE-5i |
phosphodiesterase-5 inhibitors |
PFT |
pulmonary function testing |
PH |
pulmonary hypertension |
PVR |
pulmonary vascular resistance |
QOL |
quality of life |
RHC |
right heart catheterization |
RPCT |
randomized placebo-controlled trial |
RVSP |
right ventricular systolic pressure |
SAPH |
sarcoidosis-associated pulmonary hypertension |
TRV |
tricuspid regurgitant velocity |
TTE |
transthoracic echocardiography |
V/Q |
ventilation/perfusion |
WASOG |
World Association of Sarcoidosis and other Granulomatosis |
WHO |
World Health Organization |
WU |
Wood’s units |